Normal Saline Versus Ringer's Lactate for Initial Fluid Resuscitation in Sepsis
A legfontosabb adatok
- Ki végzi
- Egemen Yildiz
- Hol
- Törökország1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toborzás még nem indult
- Fázis
- 4. fázis
- Résztvevők
- 88 fő, tervezett
- Kezdés
- 2025. nov.
- Várható befejezés
- 2026. nov.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Ringer's Lactate
- Normal Saline (0.9% Sodium Chloride)
- A regiszteradat frissítve
- 2025. november 21.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 23 feltétel megnézéseKevesebb
Ki vehet részt
- Adult male or female patients (≥18 years of age) presenting to the emergency department
- Diagnosed or suspected sepsis secondary to an infectious cause
- Provision of written informed consent by the patient, or if the patient is unable to consent, by a first-degree relative or legally authorized representative
Ki nem vehet részt
- Patients who are receiving cardiopulmonary resuscitation (CPR) or who require endotracheal intubation at the time of presentation
- Cases in which the treating physician anticipates that fluid therapy might be delayed due to study participation
- Patients with severe volume depletion unrelated to sepsis (e.g., diabetic ketoacidosis, burns, or active gastrointestinal bleeding)
- Patients with hypotension that is not related to sepsis (e.g., active hemorrhage or intracranial bleeding)
- Patients with clinical signs of pulmonary edema or congestive heart failure
- Cases in which the treating physician determines that one isotonic crystalloid (Ringer's lactate or 0.9% NaCl) is clearly superior to the other due to clinical condition or comorbidities
- Severe renal failure with oliguria or anuria
- Decompensated heart failure
- Conditions associated with impaired lactate metabolism, such as lactic acidosis, severe liver failure, and cirrhosis with ascites
- Patients with severe hyperkalemia (serum potassium level of at least 6.5 mmol/L with ECG changes)
- Known hypersensitivity to sodium lactate
- Age under 18 years old
- Pregnant women
- Informed consent was not obtained from the patient or their first-degree relative/legal guardian
- Patients requiring immediate hospital or ICU admission before completion of initial emergency department resuscitation
- Patients with sepsis sources requiring urgent invasive intervention known to directly affect mortality (e.g., an undrainable abscess or osteomyelitis); Additional exclusion criteria based on the contraindications listed in the Ringer's lactate product information:,
- Extracellular hyperhydration or hypervolemia
- Hypercalcemia
- Metabolic alkalosis or severe metabolic acidosis
- Current use of digitalis preparations (e.g., digoxin)
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
This clinical trial aims to determine if the type of intravenous fluid used for initial resuscitation affects the short-term outcomes of adult patients with sepsis who are treated in the emergency department.
A teljes eredeti leírásKevesebb
The main questions it aims to answer are:
Does using Ringer's lactate instead of 0.9% sodium chloride (normal saline) reduce 24-hour mortality in patients with sepsis?
Does the type of fluid influence other short-term outcomes, such as the need for vasopressors, mechanical ventilation, hemodialysis, and length of hospital stay?
Researchers will compare two groups of participants:
* The Ringer's lactate group (intervention group) * The 0.9% sodium chloride group (control group).
Participants will:
* Receive either Ringer's lactate or normal saline for initial fluid resuscitation as part of standard sepsis care. * They will be observed for 24 hours to assess survival and other early outcomes.
A vizsgálat 2 csoportja
- Ringer's Lactate GroupA vizsgált kezelés
Eligible participants in this group will receive Ringer's lactate solution as the initial intravenous fluid for resuscitating sepsis. This will be administered through a peripheral intravenous line at a rate of 1000 ml over 30-60 minutes, as determined by the attending physician and the patient's clinical condition. All other treatments will follow standard sepsis care protocols.
Kezelés: Ringer's Lactate
- Normal Saline GroupMár használt kezelés, összehasonlításként
Eligible participants in this arm will receive 0.9% sodium chloride (normal saline) as the initial intravenous fluid for resuscitation in sepsis. This will be administered through a peripheral intravenous line at a rate of 1000 ml over 30-60 minutes, as determined by the attending physician and the patient's clinical condition. All other treatments will follow standard sepsis care protocols.
Kezelés: Normal Saline (0.9% Sodium Chloride)
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- A Prospective, Single-Center, Randomized Controlled Trial Comparing Normal Saline and Ringer's Lactate for Initial Fluid Resuscitation in Adult Patients With Sepsis in the Emergency Department
- A regiszteradat frissítve
- 2025. november 21.